Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease

Lippuner, K; Zehnder, H J; Casez, J P; Takkinen, R; Descoeudres, C; Jaeger, P (1996). Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease. Nephrology, dialysis, transplantation, 11(1), pp. 70-4. Oxford: Oxford University Press 10.1093/oxfordjournals.ndt.a027069

Full text not available from this repository. (Request a copy)

After EDTA-induced hypocalcaemia, healthy volunteers treated with diltiazem display more severe hyperparathyroidism than subjects on felodipine studied under identical conditions. Therefore patients with end-stage renal disease (ESRD) and severe secondary hyperparathyroidism might be particularly sensitive to this side-effect.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis

UniBE Contributor:

Lippuner, Kurt

ISSN:

0931-0509

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:24

Last Modified:

17 Mar 2015 22:52

Publisher DOI:

10.1093/oxfordjournals.ndt.a027069

PubMed ID:

8649655

Web of Science ID:

A1996TU22400018

URI:

https://boris.unibe.ch/id/eprint/37879 (FactScience: 212066)

Actions (login required)

Edit item Edit item
Provide Feedback